We have pharmaceutical companies that are constantly trying to expand the indications, expand the number of people who are eligible for a given treatment, because that obviously helps their bottom line. We have advocacy groups, like the one that's come up with pre-vivor, who want to make more and more people feel they are at risk, or might have a condition, so that they can raise more funds and raise visibility, et cetera.
また製薬会社は 常に適応範囲の拡大や 治療対象者の増加を目指すものです それは確実に利益になるからです また プリバイバーを発案した患者支援団体の様に 病気のリスクや条件を満たすと 多くの人々に思わせると 多くの資金が獲得でき 知名度が上がります